MedTrace Logo

A Prospective Study Evaluating Seroprevalence and Seroconversion of Antibodies Against Adeno-associated Virus (AAV)

NCT05580692 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 321

Last updated 2024-08-19

No results posted yet for this study

Summary

A prospective cohort study utilizing biospecimen sample collection from adult Hemophilia A subjects to evaluate and characterize seroprevalence and the seroconversion of antibodies against AAV serotypes

Conditions

Interventions

PROCEDURE

Biospecimen Collection

Biospecimen Sample Collection

Sponsors & Collaborators

Principal Investigators

  • Medinfo Medinfo · BioMarin Pharmaceutical

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-14
Primary Completion
2024-07-31
Completion
2024-07-31

Countries

  • Argentina
  • Australia
  • Austria
  • Saudi Arabia
  • Sweden
  • Turkey (Türkiye)
  • United Arab Emirates

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05580692 on ClinicalTrials.gov